John D. Brunzell

16.4k total citations · 2 hit papers
147 papers, 11.5k citations indexed

About

John D. Brunzell is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, John D. Brunzell has authored 147 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Endocrinology, Diabetes and Metabolism, 61 papers in Cardiology and Cardiovascular Medicine and 44 papers in Surgery. Recurrent topics in John D. Brunzell's work include Diabetes, Cardiovascular Risks, and Lipoproteins (86 papers), Lipid metabolism and disorders (55 papers) and Lipoproteins and Cardiovascular Health (34 papers). John D. Brunzell is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (86 papers), Lipid metabolism and disorders (55 papers) and Lipoproteins and Cardiovascular Health (34 papers). John D. Brunzell collaborates with scholars based in United States, Canada and Italy. John D. Brunzell's co-authors include Jonathan Q. Purnell, Molly C. Carr, Alberto Zambon, John E. Hokanson, Amir F. Ayyobi, Ronald Goldberg, Edwin L. Bierman, Michael H. Davidson, James H. Stein and Joseph L. Witztum and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

John D. Brunzell

146 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications

2002 812 citations John D. Brunzell, Jonathan Q. Purnell et al. Diabetes Care profile →
Lipoprotein Management in Patients With Cardiometabolic Risk

2008 545 citations John D. Brunzell, Michael H. Davidson et al. Diabetes Care profile →

Peers

Countries citing papers authored by John D. Brunzell

Since Specialization

Citations

This map shows the geographic impact of John D. Brunzell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Brunzell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Brunzell more than expected).

Fields of papers citing papers by John D. Brunzell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Brunzell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Brunzell. The network helps show where John D. Brunzell may publish in the future.

Co-authorship network of co-authors of John D. Brunzell

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Brunzell. A scholar is included among the top collaborators of John D. Brunzell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Brunzell. John D. Brunzell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus 2019 ·Arteriosclerosis Thrombosis and Vascular Biology ·Baohai Shao, Leila R. Zelnick, Jake Wimberger, Jonathan Himmelfarb, John D. Brunzell, W. Sean Davidson, Janet K. Snell‐Bergeon, Karin Bornfeldt, Ian H. de Boer, Jay W. Heinecke	23
2	Genetic Disorders of Triglyceride Metabolism 2015 ·Alan Chait, Savitha Subramanian, John D. Brunzell	3
3	Effects of Niacin Combination Therapy With Statin or Bile Acid Resin on Lipoproteins and Cardiovascular Disease 2014 ·The American Journal of Cardiology ·Alberto Zambon, Xue-Qiao Zhao, B. Greg Brown, John D. Brunzell	19
4	Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Ronald Goldberg, Marinella Temprosa, James D. Otvos, John D. Brunzell, Santica M. Marcovina, Kieren J. Mather, (unknown), Karol E. Watson, Edward S. Horton, Elizabeth Barrett‐Connor	65
5	Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes 2013 ·Diabetes Care ·Michael C. Sachs, John D. Brunzell, Patricia A. Cleary, Andrew N. Hoofnagle, John M. Lachin, Mark E. Molitch, Michael W. Steffes, Bernard Zinman, Ian H. de Boer	29
6	The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus 2012 ·Circulation ·Jonathan Q. Purnell, Bernard Zinman, John D. Brunzell	192
7	A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma 2008 ·Journal of Lipid Research ·Shigeyuki Imamura, Jun Kobayashi, Katsuyuki Nakajima, Shin‐ichi Sakasegawa, Atsushi Nohara, Tohru Noguchi, Masa‐aki Kawashiri, Akihiro Inazu, S S Deeb, Hiroshi Mabuchi, John D. Brunzell	29
8	Lipoprotein Management in Patients With Cardiometabolic Risk 2008 ·Journal of the American College of Cardiology ·John D. Brunzell, Michael H. Davidson, Curt D. Furberg, Ronald Goldberg, Barbara V. Howard, James H. Stein, Joseph L. Witztum	409
9	25-Hydroxyvitamin D Levels and Albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) 2007 ·American Journal of Kidney Diseases ·Ian H. de Boer, George N. Ioannou, Bryan Kestenbaum, John D. Brunzell, Noel S. Weiss	229
10	Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study 2006 ·Journal of the American Society of Nephrology ·Ian H. de Boer, Shalamar D. Sibley, Bryan Kestenbaum, Joshua N. Sampson, Bessie A. Young, Patricia A. Cleary, Michael W. Steffes, Noel S. Weiss, John D. Brunzell	121
11	Gender and Elevated Albumin Excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort: Role of Central Obesity 2006 ·American Journal of Kidney Diseases ·Shalamar D. Sibley, William Thomas, Ian H. de Boer, John D. Brunzell, Michael W. Steffes	55
12	Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia 2005 ·Human Genetics ·France Gagnon, Gail P. Jarvik, Michael D. Badzioch, Arno G. Motulsky, John D. Brunzell, Ellen M. Wijsman	20
13	1124-192 Rosiglitazone reduces novel biomarkers of cardiovascular disease in subjects with type 2 diabetes mellitus already on statin therapy 2004 ·Journal of the American College of Cardiology ·John D. Brunzell, Santica Marcovina, Dahong Yu, Alexander R. Cobitz, Errol Gould, Hongzi Chen, Lisa A. Porter	4
14	Lipoprotein lipase and hepatic lipase 2003 ·Journal of Lipid Research ·Marian C. Cheung, Shalamar D. Sibley, Jerry P. Palmer, John F. Oram, John D. Brunzell	20
15	Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia 2003 ·Journal of Lipid Research ·Melissa A. Austin, Karen L. Edwards, Stephanie A. Monks, Kent M. Koprowicz, John D. Brunzell, Arno G. Motulsky, Michael C. Mahaney, James E. Hixson	27
16	Effect of Excessive Weight Gain With Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood Pressure 1998 ·JAMA ·Jonathan Q. Purnell, (unknown), (unknown), Michael W. Steffes, Patricia A. Cleary, John D. Brunzell	363
17	Effect of intensive diabetes therapy on diabetic dyslipidemia 1997 ·Jonathan Q. Purnell, John D. Brunzell	3
18	Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity 1992 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·(unknown), Yuanhong Ma, Michael R. Hayden, John D. Brunzell	47
19	A missense mutation Pro157Arg in lipoprotein lipase (LPL_Nijmegen) resulting in loss of catalytic activity 1992 ·European Journal of Biochemistry ·Taco Bruin, John J.P. Kastelein, D.E. van Diermen, Yuanhong Ma, Howard Henderson, (unknown), Anton F. H. Stalenhoef, Augueste Sturk, John D. Brunzell, Michael R. Hayden	13
20	[8] Single vertical spin density gradient ultracentrifugation 1986 ·Methods in enzymology on CD-ROM/Methods in enzymology ·B H Chung, Jere P. Segrest, Marjorie J. Ray, John D. Brunzell, John E. Hokanson, Ronald M. Krauss, (unknown), (unknown)	417

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact